ºÚÁϳԹÏ

Venture

As innovations in cell therapy continue to grow, San Francisco-based ArsenalBio announced it has raised a whopping $220 million in Series B funding...

67.1K Followers

CTA

Discover and act on private market opportunities with predictive company intelligence.